Emmanuelle Charpentier

Charité Berlin has successfully treated a 19-year-old patient with the world's first approved CRISPR gene-editing therapy, marking the first time the treatment has been administered in Germany since regulators approved it. The milestone is being celebrated as a landmark for medicine, with the announcement noting the work ties to CRISPR pioneer Emmanuelle Charpentier. Commenters are highlighting the significance for German healthcare and gene-editing research.